PURPOSE: Human adenovirus species D type 19 (HAdV-D19) has been associated with epidemic keratoconjunctivitis (EKC), a highly inflammatory infection of the ocular surface. Confusion exists regarding the origins of HAdV-D19. The prototype virus (HAdV-D19p) does not cause EKC, while a virus identified later with the identical serologic determinant is a significant ocular pathogen. METHODS: High throughput genome sequencing and bioinformatics analysis were performed on HAdV-D19p and three HAdV-D19 EKC strains, and compared to the previously sequenced clinical isolate, HAdV-D19 (C) and HAdV-D37. Corneas of C57BL/6J mice were injected with HAdV-D19p, HAdV-D19 (C), or virus-free buffer, and inflammation assessed by clinical examination, flow cytometry, and cytokine ELISA. Confocal microscopy and real-time PCR of infected corneal cell cultures were used to test viral entry. RESULTS: HAdV-D19 (C) and the other clinical EKC isolates showed nearly 100% sequence identity. EKC strains diverged from HAdV-D19p in the penton base, E3, and fiber transcription units. Simplot analysis showed recombination between EKC-associated HAdV-D19 with HAdV-D37, HAdV-D22, and HAdV-D19p, the latter contributing only the hexon gene, the principal serum neutralization determinant. HAdV-D19p induced stromal keratitis in the C57BL/6J mouse, but failed to infect productively human corneal epithelial cells. These data led to retyping of the clinical EKC isolates with a HAdV-D19 hexon gene as HAdV-D64. CONCLUSIONS: HAdV-D19 associated with EKC (HAdV-D64) originated from a recombination between HAdV-D19p, HAdV-D37, and HAdV-D22, and was mischaracterized because of a shared hexon gene. HAdV-D19p is not infectious for corneal epithelial cells, thus explaining the lack of any association with keratitis.
PURPOSE:Human adenovirus species D type 19 (HAdV-D19) has been associated with epidemic keratoconjunctivitis (EKC), a highly inflammatory infection of the ocular surface. Confusion exists regarding the origins of HAdV-D19. The prototype virus (HAdV-D19p) does not cause EKC, while a virus identified later with the identical serologic determinant is a significant ocular pathogen. METHODS: High throughput genome sequencing and bioinformatics analysis were performed on HAdV-D19p and three HAdV-D19 EKC strains, and compared to the previously sequenced clinical isolate, HAdV-D19 (C) and HAdV-D37. Corneas of C57BL/6J mice were injected with HAdV-D19p, HAdV-D19 (C), or virus-free buffer, and inflammation assessed by clinical examination, flow cytometry, and cytokine ELISA. Confocal microscopy and real-time PCR of infected corneal cell cultures were used to test viral entry. RESULTS: HAdV-D19 (C) and the other clinical EKC isolates showed nearly 100% sequence identity. EKC strains diverged from HAdV-D19p in the penton base, E3, and fiber transcription units. Simplot analysis showed recombination between EKC-associated HAdV-D19 with HAdV-D37, HAdV-D22, and HAdV-D19p, the latter contributing only the hexon gene, the principal serum neutralization determinant. HAdV-D19p induced stromal keratitis in the C57BL/6J mouse, but failed to infect productively human corneal epithelial cells. These data led to retyping of the clinical EKC isolates with a HAdV-D19 hexon gene as HAdV-D64. CONCLUSIONS: HAdV-D19 associated with EKC (HAdV-D64) originated from a recombination between HAdV-D19p, HAdV-D37, and HAdV-D22, and was mischaracterized because of a shared hexon gene. HAdV-D19p is not infectious for corneal epithelial cells, thus explaining the lack of any association with keratitis.
Authors: Michael Brudno; Chuong B Do; Gregory M Cooper; Michael F Kim; Eugene Davydov; Eric D Green; Arend Sidow; Serafim Batzoglou Journal: Genome Res Date: 2003-03-12 Impact factor: 9.043
Authors: Gurdeep Singh; Christopher M Robinson; Shoaleh Dehghan; Timothy Schmidt; Donald Seto; Morris S Jones; David W Dyer; James Chodosh Journal: J Virol Date: 2012-02-01 Impact factor: 5.103
Authors: Michael P Walsh; Ashish Chintakuntlawar; Christopher M Robinson; Ijad Madisch; Balázs Harrach; Nolan R Hudson; David Schnurr; Albert Heim; James Chodosh; Donald Seto; Morris S Jones Journal: PLoS One Date: 2009-06-03 Impact factor: 3.240
Authors: Christopher M Robinson; Fatemeh Shariati; Allison F Gillaspy; David W Dyer; James Chodosh Journal: BMC Genomics Date: 2008-05-09 Impact factor: 3.969
Authors: Ashrafali Mohamed Ismail; Xiaohong Zhou; David W Dyer; Donald Seto; Jaya Rajaiya; James Chodosh Journal: FEBS Lett Date: 2019-12-11 Impact factor: 4.124
Authors: Gurdeep Singh; Christopher M Robinson; Shoaleh Dehghan; Morris S Jones; David W Dyer; Donald Seto; James Chodosh Journal: J Virol Date: 2013-09-11 Impact factor: 5.103
Authors: Mark Windheim; Jennifer H Southcombe; Elisabeth Kremmer; Lucy Chaplin; Doris Urlaub; Christine S Falk; Maren Claus; Janine Mihm; Myles Braithwaite; Kevin Dennehy; Harald Renz; Martina Sester; Carsten Watzl; Hans-Gerhard Burgert Journal: Proc Natl Acad Sci U S A Date: 2013-11-11 Impact factor: 11.205
Authors: Aengus Mac Sweeney; Philipp Grosche; David Ellis; Keith Combrink; Paul Erbel; Nicola Hughes; Finton Sirockin; Samu Melkko; Anna Bernardi; Paul Ramage; Nadine Jarousse; Eva Altmann Journal: ACS Med Chem Lett Date: 2014-06-20 Impact factor: 4.345
Authors: Cecilia S Lee; Aaron Y Lee; Lakshmi Akileswaran; David Stroman; Kathryn Najafi-Tagol; Steve Kleiboeker; James Chodosh; Amalia Magaret; Anna Wald; Russell N Van Gelder Journal: Ophthalmology Date: 2018-03-27 Impact factor: 12.079
Authors: Gurdeep Singh; Xiaohong Zhou; Jeong Yoon Lee; Mohammad A Yousuf; Mirja Ramke; Ashrafali M Ismail; Ji Sun Lee; Christopher M Robinson; Donald Seto; David W Dyer; Morris S Jones; Jaya Rajaiya; James Chodosh Journal: Virology Date: 2015-09-07 Impact factor: 3.616